Profound Medical(PROF)
Focus: Profound Medical is a public biotech company focused on real-time MRI-guided medical devices for oncology, specifically prostate cancer treatment. The company operates as a mid-cap, pre-revenue-to-early-revenue medical device innovator with a Canadian headquarters.
Profile data last refreshed 4h ago · AI intelligence enriched 3w ago
Funding Stage
PUBLIC
Open Jobs
17-3 this month
Stable — net -3 jobs in 30d
5 added, 8 removed. Backfill posture.
Should You Work at Profound Medical?
AI assessmentBest fit for early-career or mission-driven specialists willing to tolerate pre-profitability risk in exchange for hands-on device innovation and commercial launch experience.
Why Work Here
- High R&D intensity (159%) signals heavy investment in novel MRI-guided surgical technology development with meaningful technical depth.
- Public company status provides equity upside and career visibility; recent investor attention as an 'AI Healthcare' stock suggests market momentum.
Data completeness
5/9 — Partial
Company HealthStrong
Pipeline
Early-stage
4 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Revenue
$11M
Pipeline & Clinical Trials
Radical Prostatectomy
Prostate CancerClinical Trials (1)
NCT05027477A Comparison of TULSA Procedure vs. Radical Prostatectomy in Participants With Localized Prostate Cancer
N/AHelp build intelligence for Profound Medical
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.